These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 65996

  • 1. [Active role of phosphodiesterases in regulation of cyclic AMP metabolism in the thyroid gland (proceedings)].
    Erneux C, Boeynaems JM, Van Sande J, Dumont JE.
    Arch Int Physiol Biochim; 1976 Dec; 84(5):1070-2. PubMed ID: 65996
    [No Abstract] [Full Text] [Related]

  • 2. [Cyclic nucleotides phosphodiesterases inhibitors].
    Hagiwara M, Hidaka H.
    Nihon Rinsho; 1991 Sep; 49(9):1993-8. PubMed ID: 1660084
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens.
    Seftel AD.
    J Urol; 2005 Sep; 174(3):1043. PubMed ID: 16094045
    [No Abstract] [Full Text] [Related]

  • 6. Cyclic nucleotide phosphodiesterase 5 and sildenafil: promises realized.
    Manganiello V.
    Mol Pharmacol; 2003 Jun; 63(6):1209-11. PubMed ID: 12761329
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Possibilities for drug development based on the cyclic AMP system.
    Amer MS, McKinney GR.
    Life Sci; 1973 Oct 01; 13(7):753-67. PubMed ID: 4358272
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.
    Gupta R, Kumar G, Kumar RS.
    Methods Find Exp Clin Pharmacol; 2005 Mar 01; 27(2):101-18. PubMed ID: 15834463
    [Abstract] [Full Text] [Related]

  • 17. Phosphodiesterase genes and antidepressant treatment response: a review.
    Esposito K, Reierson GW, Luo HR, Wu GS, Licinio J, Wong ML.
    Ann Med; 2009 Mar 01; 41(3):177-85. PubMed ID: 18932104
    [Abstract] [Full Text] [Related]

  • 18. Influence of divalent cations on regulation of cyclic GMP and cyclic AMP levels in brain tissue.
    Ferrendelli JA, Rubin EH, Kinscherf DA.
    J Neurochem; 1976 Apr 01; 26(4):741-8. PubMed ID: 184244
    [No Abstract] [Full Text] [Related]

  • 19. Negative regulation of cyclic AMP levels by activation of cyclic nucleotide phosphodiesterases: the example of the dog thyroid.
    Dumont JE, Miot F, Erneux C, Couchie D, Cochaux P, Gervy-Decoster C, Van Sande J, Wells JN.
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984 Apr 01; 16():325-36. PubMed ID: 6202125
    [No Abstract] [Full Text] [Related]

  • 20. Cyclic nucleotide phosphodiesterases.
    Essayan DM.
    J Allergy Clin Immunol; 2001 Nov 01; 108(5):671-80. PubMed ID: 11692087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.